Byron Robinson Janux Therapeutics, Inc. (JANX) insider trading activity
Byron Robinson is Chief Strategy Officer of Janux Therapeutics, Inc.. Currently has a direct ownership of 28,000 shares of JANX, which is worth approximately $1.23 Million. The most recent transaction as insider was on Jan 02, 2025, when has been sold 28,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
28K
n/a
3M change
n/a
12M change
Total Value Held
$1.23 Million
BR
Byron Robinson
Chief Strategy Officer
La Jolla, CA